Antiretroviral therapy coverage in IDA total
IDA total: Antiretroviral therapy coverage was 82.1% in 2024. ◆ Volatile
Antiretroviral therapy coverage in IDA total, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in IDA total is 82.1%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 4.2% on the previous year and up 98.1% over ten years.
Over the whole period, antiretroviral therapy coverage in IDA total peaked at 82.1% in 2024 and was at its lowest, 0.2%, in 2000.
IDA total ranks 12th of 23 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in IDA total, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.2% | — |
| 2001 | 0.3% | +29.7% |
| 2002 | 0.4% | +34.6% |
| 2003 | 0.6% | +58.5% |
| 2004 | 2.0% | +207.1% |
| 2005 | 3.5% | +74.2% |
| 2006 | 6.0% | +73.7% |
| 2007 | 9.5% | +57.0% |
| 2008 | 13.5% | +42.8% |
| 2009 | 17.5% | +29.0% |
| 2010 | 21.7% | +24.4% |
| 2011 | 25.7% | +18.4% |
| 2012 | 30.6% | +19.0% |
| 2013 | 35.7% | +16.8% |
| 2014 | 41.5% | +16.0% |
| 2015 | 46.7% | +12.6% |
| 2016 | 52.2% | +11.8% |
| 2017 | 58.2% | +11.5% |
| 2018 | 60.9% | +4.6% |
| 2019 | 64.9% | +6.7% |
| 2020 | 68.7% | +5.8% |
| 2021 | 72.0% | +4.9% |
| 2022 | 75.7% | +5.0% |
| 2023 | 78.8% | +4.1% |
| 2024 | 82.1% | +4.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.4% | 0.2% | 17.5% | 10 |
| 2010s | 43.8% | 21.7% | 64.9% | 10 |
| 2020s | 75.5% | 68.7% | 82.1% | 5 |
Countries ranked near IDA total
More health data for IDA total
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population, male, annual growth rate 2.11 % change on previous year (2025)
- Population, female, per capita 0.5007 units per person (2025)
- Population, female, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population, female, annual growth rate 2.12 % change on previous year (2025)
- Population ages 65 and above, total, per capita 0.0396 units per person (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, annual growth rate 3.7 % change on previous year (2025)
- Population ages 65 and above, male, per capita 0.0179 units per person (2025)
- Population ages 15-64, total, annual growth rate 2.57 % change on previous year (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in IDA total?
- Antiretroviral therapy coverage in IDA total was 82.1% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in IDA total?
- The highest recorded value was 82.1% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in IDA total?
- The lowest recorded value was 0.2% in 2000.
- How does IDA total rank for antiretroviral therapy coverage?
- IDA total ranks 12th out of 23 groups with data for 2024.
- Is antiretroviral therapy coverage rising or falling in IDA total?
- Over the last ten years it is up 98.1%. The long-run trend across the full record is volatile.
- Where does this IDA total data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.